Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2001-05-22
Product name
"VERTREL"
Icons in SDS
Company Information
company name
DuPont Fluoroproducts
Section 2
Potential health effects
Gross overexposure by inhalation to HFC-43-10mee may cause suffocation if air is displaced by vapors and central nervous system stimulation with increased activity or sleeplessness, tremors or convulsions. These effects may be followed by central nervous system depression with Continued) dizziness, confusion, incoordination, drowsiness or unconsciousness. Based on data from other fluorocarbons, gross overexposure to HFC-43-10mee may cause irregular heart beat with a strange sensation in the chest, "heart thumping" apprehension, lightheadedness, feeling of fainting, dizziness, weakness, sometimes progressing to loss of consciousness and death. Intentional misuse or deliberate inhalation may cause death without warning. Vapor reduces oxygen available for breathing and is heavier than air. Immediate effects of overexposure to HFC-43-10mee by skin contact may include slight irritation with itching, redness or swelling. Repeated and/or prolonged exposure may cause defatting of the skin with itching, redness or rash. Based on animal data, significant skin permeation, and systemic toxicity after skin contact, appears unlikely. Immediate effects of overexposure to HFC-43-10mee by eye contact may include eye irritation with tearing, pain or blurred vision. The major ingestion hazard of HFC-43-10mee is aspiration (liquid entering the lungs during ingestion or vomiting) which may result in "chemical pneumonia." Symptoms include coughing, gasping, choking, shortness of breath, bluish discoloration of the skin, rapid breathing and heart rate, and fever. Pulmonary edema or bleeding, drowsiness, confusion, coma and seizures may occur in more serious cases. Symptoms may develop immediately or as late as 24 hours after exposure, depending on how much chemical entered the lungs. Increased susceptibility to the effects of HFC-43-10mee may be observed in persons with pre-existing disease of the central nervous system or the cardiovascular system. Based on animal data, HFC-365mfc may cause eye irritation with tearing, pain or blurred vision. Repeated skin contact may cause drying and cracking. Inhalation of HFC-365mfc may cause central nervous system depression with dizziness, confusion, incoordination, drowsiness or unconsciousness. Gross overexposure by inhalation may cause irregular heart beat with a strange sensation in the chest, "heart thumping", apprehension, lightheadedness, feeling of fainting, dizziness, weakness, sometimes progressing to loss of consciousness and death. Inhalation of t-DCE may cause central nervous system depression with dizziness, confusion, incoordination, drowsiness or unconsciousness; or tremors, nausea, vomiting, weakness, and abdominal cramps. Other effects may include irregular heart beat with a strange sensation in the chest, "heart thumping",apprehension, lightheadedness, feeling of fainting, dizziness, or weakness. Skin contact with t-DCE may cause severe irritation with burning, redness, swelling, pain or rash. Eye contact with t-DCE may cause severe eye irritation with tearing, pain or blurred vision. Ingestion of t-DCE may cause pulmonary edema (body fluid in the lungs) with cough, wheezing, abnormal lung sounds, possibly Continued) progressing to severe shortness of breath and bluish discoloration of the skin: symptoms may be delayed. Ingestion may also cause pathological changes in the liver, central nervous system depression with dizziness, confusion, incoordination, drowsiness or unconsciousness, and structural (pathological) changes in heart muscle tissue. Carcinogenicity Information None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC, NTP, OSHA or ACGIH as a carcinogen. ----------------------------------------------------------------------